Target intelligence / Profile preview

Reactive oxygen species generation in Plasmodium-infected erythrocytes

Molecular classification
Other (biochemical process, not a discrete molecule)
01

Overview

Reactive oxygen species (ROS) generation in Plasmodium-infected erythrocytes is a process arising from both host and parasite metabolism during malaria infection, primarily involving hydrogen peroxide, superoxide, and hydroxyl radicals. ROS are produced in the food vacuole of the parasite during hemoglobin digestion and also by host enzymes such as xanthine oxidase and phagocyte NADPH oxidase. While ROS contribute to oxidative damage and inflammation in malaria pathogenesis—including the development of severe complications—they also have a host-protective role by inhibiting parasite growth. In malaria patients, especially during severe disease, elevated ROS (notably from upregulated xanthine oxidase) drive inflammation and tissue damage, as well as providing signals for inflammasome activation[1][2][4][5][6][7].

Other names
ROS generation in malariaoxidative stress in Plasmodium-infected erythrocytesreactive oxygen species in malaria
02

Mechanism of action

Scavenging or reduction of ROS to mitigate cellular damage[5][6][7] Inhibition of xanthine oxidase to reduce ROS-mediated inflammation[5][6]

03

Biological functions

Oxidative stressHost-pathogen interactionInflammation inductionCellular damage
04

Disease associations

InfectionMalaria pathogenesisInflammation
05

Safety considerations

General antioxidant therapy may interfere with immune clearance of infectionInhibition of ROS can blunt inflammation but may permit greater parasite survival[5][7]
06

Interacting drugs

Antioxidants (e.g., vitamin E)

1 more in the full profile.

07

Biomarkers

Plasma xanthine oxidase activityLipid peroxidation products (e.g., malondialdehyde)Catalase and glutathione levels

Beyond the preview

Go deeper on Reactive oxygen species generation in Plasmodium-infected erythrocytes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species generation in Plasmodium-infected erythrocytes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call